pared with treatment regimens without tetracycline, the OR in favor of doxycycline was even higher: OR 1.59, 95% CI 1.21-2.09, p < 0.001. Conclusion: In this meta-analysis, we confirmed doxycycline efficiency in the eradication of H. pylori . Thus, triple, quadruple or even high dose dual therapy with regimens containing doxycycline should be considered.
But the results of the paper by Realdi et al. [3] were somewhat confusing because of the high resistance rate not only to doxycycline (33.3%), but also to amoxicillin (26%). In contrast, Usta et al. [4] found a higher eradication rate in a second-line quadruple therapy including doxycycline than 2 first-line triple therapies in children, 64.6 versus 60.5 and 55.8%, respectively. Recently, a combination of esomeprazole, levofloxacin and doxycycline was tried as a third-line therapy with a low eradication efficacy that was somewhat enhanced with probiotics [5] .
In this meta-analysis, we looked at studies that compared the eradication success rate of H. pylori treatment regimens with and without doxycycline. A high rate of successful eradication will give legitimation to use doxycycline instead of amoxicillin in cases of penicillin allergy or as a rescue quadruple therapy.
Methods

Search Strategy
English medical literature searches were conducted for treatment regimens which included doxycycline for eradication of H. pylori . Searches were performed through August 31, 2015, using MEDLINE, PubMed, EMBASE, Scopus and CENTRAL. Search terms were: ('doxycycline'(MeSH Terms) OR 'doxycycline'(All Fields)) AND ('Helicobacter pylori'(MeSH Terms) OR ('Helicobacter'(All Fields) AND 'pylori'(All Fields)) OR 'Helicobacter pylori'(All Fields)). Hand searches of articles were performed after the initial search, and included article bibliography. Only fully published human studies in English were included ( fig. 1 ).
Study Selection
Case-control studies comparing treatment regimens for eradication of H. pylori , with and without doxycycline, were included. H. pylori infection should be diagnosed with 13 C-urea breath test, stool antigen, rapid urease test or histology and successful eradication with one of the same tests, at least a month after treatment, and at least 2 weeks without antibiotics, bismuth or proton pump inhibitor therapy. We selected only randomized, prospective, controlled studies that used intention to treat method to express the results.
Data Extraction
Successful eradication rates were extracted for treatment regimens with and without doxycycline. In studies where sub-studies were performed, such as comparison of first and second regimens, gender, treatment specification such as triple, quadruple, concomitant or sequential regimens, their results were compared in innate studies.
Meta-analysis was performed by using comprehensive metaanalysis software (version 3, Biostat Inc., Englewood, N.J., USA). Pooled ORs and 95% CIs were calculated comparing eradication success rate in individual studies by using the fixed effects model. Heterogeneity between studies was evaluated using the Cochran Q test, and it was considered to be present if the Q test p value was <0.10. I 2 statistic was used to measure the proportion of inconsistency in individual studies, with I 2 >50% representing substantial heterogeneity. We also calculated a potential publication bias.
Results
All together we found 53 eligible studies. Twenty-one studies were rejected because of language, for being performed in animals or not having full text. Twenty-four papers were excluded being editorials, review articles or because of duplications. We were left with 8 case-control studies from 8 countries, comparing eradication treatments of H. pylori with or without doxycycline, that fulfilled the inclusion criteria, published till August 31, 2015 [2, 3, [6] [7] [8] [9] [10] [11] ( fig. 1 ; table 1 ). There are 15 sub-studies (innate studies, stratifying data according to treatment regimen or duration). In the study from Texas [3] , 5 substudies have been performed, comparing the same doxycycline regimen with 5 different regimens without doxycycline. The studies from Italy, Iran and New York [6, 8, 10] ( table 1 ) [2, 3, 6, 10] . In 5 sub-studies, treatment regimens with doxycycline had significantly higher eradication rate than treatment regimens without doxycycline ( table 1 ) [3, 6, 10] . In 3 sub-studies, treatment regimens without doxycycline have done better ( table 1 ) [2, 3] . In 6 sub-studies, treatment regimens with doxycycline were compared with treatment regimens containing tetracycline ( table 1 ) [2, 3, 6, 9, 11] . In 2 sub-studies tetracycline was better [2, 3] , in 1 substudy doxycycline was better [6] and in the other no difference between them was demonstrated ( table 1 ) [6, 9, 11] .
The OR for eradication rate in a fixed model was in favor for treatment regimens with doxycycline: 1.292, 95% CI 1.048-1.594, p = 0.016 ( fig. 2 ) . Funnel plot denies a significant publication bias ( fig. 3 ). There was no significant heterogeneity in the included studies: Q = 15.130, d.f. (Q) = 8, I 2 = 47.126, p > 0.10. When only treatment regimens with doxycycline were compared with treatment regimens with tetracycline, no significant difference was found in eradication success rate: OR 0.95, 95% CI 0.68-1.32, p = 0.77 ( fig. 2 a) . But when treatment regimens with doxycycline were compared with treatment regimens without tetracycline, the OR in favor of doxycycline was even higher: OR 1.59, 95% CI 1.21-2.09, p < 0.001.
Discussion
Doxycycline was clinically developed in the early 1960s and approved by the FDA in 1967 [12] . It belongs to the tetracycline group of antibiotics, with improved stability and pharmacological efficacy. Tetracycline and doxycycline have therapeutic range similar to penicillin, thus, theoretically could replace amoxicillin in the treatment regimen for H. pylori . This may be especially important in patients allergic to penicillin. Both drugs, tetracycline and doxycycline, act systemically after absorption from the upper gastrointestinal tract. The main advantage of doxycycline over tetracycline is its longer activity, and it can be taken twice or once a day. The peak concentration of both drugs is similar, but in the case of doxycycline the time to peak concentration is shorter, and half life is significantly longer [13] . In this meta-analysis, we confirmed doxycycline efficiency in the eradication of H. pylori . Treatment regimens containing doxycycline had a similar eradication success rate as regimens containing tetracycline, but better than those without a representative of the tetracycline family of antibiotics. When treatment regimens with tetracycline HCL were excluded, the OR for doxycycline containing regimens reached 1.59 and is very significant (p < 0.001).
I believe that according to this meta-analysis, triple, quadruple or even high dose dual therapy with regimens containing doxycycline will be considered as a therapeutic option. This observation is particularly important in the era of drug resistance and the increasing need for alternative eradication regimens and rescue therapy [14] .
This study is limited by the lack of many trials with treatment regimens containing doxycycline, reporting only 8 case-control studies. In addition, some of the studies described first-line therapy and some rescue therapy, thus eradication success varied and was <85%. Thus, the results should be taken with caution, and more randomized controlled studies are needed for final conclusions.
Summary
In this meta-analysis, we looked at studies that compared the eradication success rate of H. pylori treatment regimens with and without doxycycline. The OR for eradication rate in a fixed model was in favor for treatment regimens with doxycycline: 1.292, 95% CI 1.048-1.594, p = 0.016. There was no significant heterogeneity in the included studies: Q = 15.130, d.f. (Q) = 8, I 2 = 47.126, p > 0.10. When treatment regimens with doxycycline were compared only with treatment regimens with tetracycline, no significant difference was found in eradication success rate. But, when treatment regimens with doxycycline were compared with treatment regimens without tetracycline, the OR in favor of doxycycline was even higher. Thus, triple, quadruple or even high dose dual therapy with regimens containing doxycycline should be considered.
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